Emerald Mutual Fund Advisers Trust’s Alamar Biosciences ALMR Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio ALMR Stock Details ALMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4M	Buy	+422,127	New	+$9.55M	0.4%	94

Other funds holding ALMR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

DACS

Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's ALMR Position: Q2 2026 in Review

Emerald Mutual Fund Advisers Trust opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 422,127 shares worth $11.4M. The stake represents 0.4% of the portfolio and ranks #94 among its holdings.

17 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

Emerald Mutual Fund Advisers Trust held 422,127 shares of Alamar Biosciences worth $11.4M as of Q2 2026.
Alamar Biosciences was a new Emerald Mutual Fund Advisers Trust position in Q2 2026.
Alamar Biosciences made up 0.4% of Emerald Mutual Fund Advisers Trust's portfolio in Q2 2026, its #94 holding.
17 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2026, filed 5 Aug 2026.